Pay vs Performance Disclosure - USD ($)

12 Months Ended

Dec. 31, 2024

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Pay vs Performance Disclosure

Pay vs Performance Disclosure, Table

Pay Versus Performance

					Value of Initial Fixed $100 Investment Based on:
Year	Summary Compensation Table Total for PEO ($)(1)	Compensation Actually Paid to PEO ($)(2)	Average Summary Compensation Table Total for non-PEO NEOs ($)(3)	Average Compensation Actually Paid to non-PEO NEOs ($)(2)	SBRA Total Shareholder Return ($)(4)	NAREIT Health Care Total Shareholder Return ($)(5)	Net Income ($M)(6)		Adjusted Normalized FFO Per Share ($)((7)(8)
2024	8,481,297	14,344,647	3,615,003	5,444,544	123.36	115.44	126.71		1.48
2023	8,219,499	12,212,423	3,259,707	4,361,230	94.05	94.40	13.76		1.38
2022	6,652,517	7,288,778	2,414,421	2,550,429	74.54	81.59	(77.61	)	1.54
2021	6,091,584	1,132,584	1,741,895	447,643	74.20	104.85	(113.26	)	1.62
2020	5,455,333	3,045,161	2,119,717	1,172,025	88.53	90.14	138.42		1.82

(1) Reflects compensation amounts reported in the Summary Compensation Table for our Chair and Chief Executive Officer, Richard K. Matros, for the respective years shown.

(2) The dollar amounts reported represent the amount of “compensation actually paid” to our Chair and Chief Executive Officer and the average of non-Chief Executive Officer Named Executive Officers, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation earned by or paid during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to total compensation for each year to determine the compensation actually paid:

	2020				2021				2022				2023				2024
Adjustments	PEO ($)		Average Non- PEO NEOs ($)		PEO ($)		Average Non- PEO NEOs ($)		PEO ($)		Average Non- PEO NEOs ($))		PEO ($)		Average Non- PEO NEOs ($)		PEO ($)		Average Non- PEO NEOs ($)
Reported Summary Compensation Table Total		5,455,333		2,119,717		6,091,584		1,741,895		6,652,517		2,414,421		8,219,499		3,259,707		8,481,297		3,615,003
Deduction for Amounts Reported under the “Stock Awards” and “Option Awards” Columns in the Summary Compensation Table for Applicable FY		(3,517,458)		(1,407,392)		(4,047,334)		(977,678)		(4,129,117)		(1,352,381)		(4,519,499)		(1,506,507)		(4,781,297)		(1,711,203)
Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Remain Unvested as of Applicable FY End, determined as of Applicable FY End		3,409,048		1,071,410		3,790,585		681,645		4,071,408		1,241,284		4,467,554		1,489,191		4,819,753		1,724,966
Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Vested during Applicable FY, determined as of Vesting Date		–		332,495		–		193,896		–		74,929		–		–		–		–
Increase/deduction for Awards Granted during Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End		(1,297,659)		(458,766)		(2,169,499)		(533,341)		629,203		159,830		3,237,237		923,533		4,971,111		1,576,975
Increase/deduction for Awards Granted during Prior FY that Vested During Applicable FY, determined based on change in ASC 718 Fair Value from Prior FY End to Vesting Date		(1,004,103)		(485,439)		(2,532,752)		(658,774)		64,767		12,346		807,631		195,306		853,783		238,803
Deduction of ASC 718 Fair Value of Awards Granted during Prior FY that were Forfeited during Applicable FY, determined as of Prior FY End		–		–		–		–		–		–		–		–		–		–
Increase based on Dividends or Other Earnings Paid during Applicable FY prior to Vesting Date		–		–		–		–		–		–		–		–		–		–
Increase based on Incremental Fair Value of Options/SARs Modified during Applicable FY		–		–		–		–		–		–		–		–		–		–
TOTAL ADJUSTMENTS		(2,410,172)		(947,692)		(4,959,000)		(1,294,252)		636,261		136,008		3,992,923		1,101,523		5,863,350		1,829,541
COMPENSATION ACTUALLY PAID		3,045,161		1,172,025		1,132,584		447,643		7,288,778		2,550,429		12,212,423		4,361,230		14,344,647		5,444,544

(3) The following are our non-Chief Executive Officer Named Executive Officers for each of the years reflected in the table above:

  2024: Talya Nevo-Hacohen and Michael L. Costa

  2023: Talya Nevo-Hacohen and Michael L. Costa

  2022: Talya Nevo-Hacohen and Michael L. Costa

  2021: Talya Nevo-Hacohen, Michael L. Costa and Harold Andrews

  2020: Talya Nevo-Hacohen and Harold Andrews

(4) Cumulative total shareholder return is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between Sabra’s share price at the end and the beginning of the measurement period by Sabra’s share price at the beginning of the measurement period. Values for periods prior to 2024 have been updated to accurately reflect dividend reinvestment over the total period presented.

(5) Peer group used for this purpose is the following published industry index: Nareit Health Care Property Sector Total Return Index.

(6) The dollar amounts reported represent the amount of net income in millions reflected in the Company’s audited financial statements for the applicable year.

(7) Financial Performance Measures. Listed below are the financial performance measures which in our assessment represent the most important financial performance measures we use to link compensation actually paid to our Named Executive Officers, for 2024, to Sabra’s performance:

  Adjusted Normalized FFO Per Share

  Total Shareholder Return

(8) Below are graphs showing the relationship of “compensation actually paid” to our Chief Executive Officer and other Named Executive Officers in 2020, 2021, 2022, 2023 and 2024 to (1) TSR of both Sabra and the Nareit Health Care Property Sector Total Return Index, (2) Sabra’s net income and (3) Sabra’s adjusted normalized FFO per share.

Company Selected Measure Name

Adjusted Normalized FFO Per Share

Named Executive Officers, Footnote

(3) The following are our non-Chief Executive Officer Named Executive Officers for each of the years reflected in the table above:

  2024: Talya Nevo-Hacohen and Michael L. Costa

  2023: Talya Nevo-Hacohen and Michael L. Costa

  2022: Talya Nevo-Hacohen and Michael L. Costa

  2021: Talya Nevo-Hacohen, Michael L. Costa and Harold Andrews

  2020: Talya Nevo-Hacohen and Harold Andrews

Peer Group Issuers, Footnote

Peer group used for this purpose is the following published industry index: Nareit Health Care Property Sector Total Return Index.

PEO Total Compensation Amount

$ 8,481,297

$ 8,219,499

$ 6,652,517

$ 6,091,584

$ 5,455,333

PEO Actually Paid Compensation Amount

$ 14,344,647

12,212,423

7,288,778

1,132,584

3,045,161

Adjustment To PEO Compensation, Footnote

	2020				2021				2022				2023				2024
Adjustments	PEO ($)		Average Non- PEO NEOs ($)		PEO ($)		Average Non- PEO NEOs ($)		PEO ($)		Average Non- PEO NEOs ($))		PEO ($)		Average Non- PEO NEOs ($)		PEO ($)		Average Non- PEO NEOs ($)
Reported Summary Compensation Table Total		5,455,333		2,119,717		6,091,584		1,741,895		6,652,517		2,414,421		8,219,499		3,259,707		8,481,297		3,615,003
Deduction for Amounts Reported under the “Stock Awards” and “Option Awards” Columns in the Summary Compensation Table for Applicable FY		(3,517,458)		(1,407,392)		(4,047,334)		(977,678)		(4,129,117)		(1,352,381)		(4,519,499)		(1,506,507)		(4,781,297)		(1,711,203)
Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Remain Unvested as of Applicable FY End, determined as of Applicable FY End		3,409,048		1,071,410		3,790,585		681,645		4,071,408		1,241,284		4,467,554		1,489,191		4,819,753		1,724,966
Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Vested during Applicable FY, determined as of Vesting Date		–		332,495		–		193,896		–		74,929		–		–		–		–
Increase/deduction for Awards Granted during Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End		(1,297,659)		(458,766)		(2,169,499)		(533,341)		629,203		159,830		3,237,237		923,533		4,971,111		1,576,975
Increase/deduction for Awards Granted during Prior FY that Vested During Applicable FY, determined based on change in ASC 718 Fair Value from Prior FY End to Vesting Date		(1,004,103)		(485,439)		(2,532,752)		(658,774)		64,767		12,346		807,631		195,306		853,783		238,803
Deduction of ASC 718 Fair Value of Awards Granted during Prior FY that were Forfeited during Applicable FY, determined as of Prior FY End		–		–		–		–		–		–		–		–		–		–
Increase based on Dividends or Other Earnings Paid during Applicable FY prior to Vesting Date		–		–		–		–		–		–		–		–		–		–
Increase based on Incremental Fair Value of Options/SARs Modified during Applicable FY		–		–		–		–		–		–		–		–		–		–
TOTAL ADJUSTMENTS		(2,410,172)		(947,692)		(4,959,000)		(1,294,252)		636,261		136,008		3,992,923		1,101,523		5,863,350		1,829,541
COMPENSATION ACTUALLY PAID		3,045,161		1,172,025		1,132,584		447,643		7,288,778		2,550,429		12,212,423		4,361,230		14,344,647		5,444,544

Non-PEO NEO Average Total Compensation Amount

$ 3,615,003

3,259,707

2,414,421

1,741,895

2,119,717

Non-PEO NEO Average Compensation Actually Paid Amount

$ 5,444,544

4,361,230

2,550,429

447,643

1,172,025

Adjustment to Non-PEO NEO Compensation Footnote

	2020				2021				2022				2023				2024
Adjustments	PEO ($)		Average Non- PEO NEOs ($)		PEO ($)		Average Non- PEO NEOs ($)		PEO ($)		Average Non- PEO NEOs ($))		PEO ($)		Average Non- PEO NEOs ($)		PEO ($)		Average Non- PEO NEOs ($)
Reported Summary Compensation Table Total		5,455,333		2,119,717		6,091,584		1,741,895		6,652,517		2,414,421		8,219,499		3,259,707		8,481,297		3,615,003
Deduction for Amounts Reported under the “Stock Awards” and “Option Awards” Columns in the Summary Compensation Table for Applicable FY		(3,517,458)		(1,407,392)		(4,047,334)		(977,678)		(4,129,117)		(1,352,381)		(4,519,499)		(1,506,507)		(4,781,297)		(1,711,203)
Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Remain Unvested as of Applicable FY End, determined as of Applicable FY End		3,409,048		1,071,410		3,790,585		681,645		4,071,408		1,241,284		4,467,554		1,489,191		4,819,753		1,724,966
Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Vested during Applicable FY, determined as of Vesting Date		–		332,495		–		193,896		–		74,929		–		–		–		–
Increase/deduction for Awards Granted during Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End		(1,297,659)		(458,766)		(2,169,499)		(533,341)		629,203		159,830		3,237,237		923,533		4,971,111		1,576,975
Increase/deduction for Awards Granted during Prior FY that Vested During Applicable FY, determined based on change in ASC 718 Fair Value from Prior FY End to Vesting Date		(1,004,103)		(485,439)		(2,532,752)		(658,774)		64,767		12,346		807,631		195,306		853,783		238,803
Deduction of ASC 718 Fair Value of Awards Granted during Prior FY that were Forfeited during Applicable FY, determined as of Prior FY End		–		–		–		–		–		–		–		–		–		–
Increase based on Dividends or Other Earnings Paid during Applicable FY prior to Vesting Date		–		–		–		–		–		–		–		–		–		–
Increase based on Incremental Fair Value of Options/SARs Modified during Applicable FY		–		–		–		–		–		–		–		–		–		–
TOTAL ADJUSTMENTS		(2,410,172)		(947,692)		(4,959,000)		(1,294,252)		636,261		136,008		3,992,923		1,101,523		5,863,350		1,829,541
COMPENSATION ACTUALLY PAID		3,045,161		1,172,025		1,132,584		447,643		7,288,778		2,550,429		12,212,423		4,361,230		14,344,647		5,444,544

Compensation Actually Paid vs. Total Shareholder Return

Compensation Actually Paid vs. Net Income

Compensation Actually Paid vs. Company Selected Measure

Total Shareholder Return Amount

$ 123.36

94.05

74.54

74.2

88.53

Peer Group Total Shareholder Return Amount

115.44

94.4

81.59

104.85

90.14

Net Income (Loss)

$ 126,710,000

$ 13,760,000

$ (77,610,000)

$ (113,260,000)

$ 138,420,000

Company Selected Measure Amount

1.48

1.38

1.54

1.62

1.82

PEO Name

Richard K. Matros

Measure:: 1

Pay vs Performance Disclosure

Name

Adjusted Normalized FFO Per Share

Measure:: 2

Pay vs Performance Disclosure

Name

Total Shareholder Return

PEO | Equity Awards Adjustments

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

$ 5,863,350

$ 3,992,923

$ 636,261

$ (4,959,000)

$ (2,410,172)

PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

(4,781,297)

(4,519,499)

(4,129,117)

(4,047,334)

(3,517,458)

PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

4,819,753

4,467,554

4,071,408

3,790,585

3,409,048

PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

4,971,111

3,237,237

629,203

(2,169,499)

(1,297,659)

PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

853,783

807,631

64,767

(2,532,752)

(1,004,103)

Non-PEO NEO | Equity Awards Adjustments

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

1,829,541

1,101,523

136,008

(1,294,252)

(947,692)

Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

(1,711,203)

(1,506,507)

(1,352,381)

(977,678)

(1,407,392)

Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

1,724,966

1,489,191

1,241,284

681,645

1,071,410

Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

1,576,975

923,533

159,830

(533,341)

(458,766)

Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

74,929

193,896

332,495

Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

$ 238,803

$ 195,306

$ 12,346

$ (658,774)

$ (485,439)